NO20034471D0 - Aryl (eller heteroaryl)-azolylkarbinolderivater for behandling av respiratoriske sykdommer - Google Patents

Aryl (eller heteroaryl)-azolylkarbinolderivater for behandling av respiratoriske sykdommer

Info

Publication number
NO20034471D0
NO20034471D0 NO20034471A NO20034471A NO20034471D0 NO 20034471 D0 NO20034471 D0 NO 20034471D0 NO 20034471 A NO20034471 A NO 20034471A NO 20034471 A NO20034471 A NO 20034471A NO 20034471 D0 NO20034471 D0 NO 20034471D0
Authority
NO
Norway
Prior art keywords
heteroaryl
aryl
treatment
radical
respiratory diseases
Prior art date
Application number
NO20034471A
Other languages
English (en)
Other versions
NO20034471L (no
Inventor
Ramon Merce-Vidal
Blas Andaluz-Matero
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO20034471D0 publication Critical patent/NO20034471D0/no
Publication of NO20034471L publication Critical patent/NO20034471L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20034471A 2001-04-06 2003-10-06 Aryl (eller heteroaryl)-azolylkarbinolderivater for behandling av respiratoriske sykdommer NO20034471L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200100817A ES2174756B2 (es) 2001-04-06 2001-04-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
PCT/ES2002/000136 WO2002080908A1 (es) 2001-04-06 2002-03-21 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias

Publications (2)

Publication Number Publication Date
NO20034471D0 true NO20034471D0 (no) 2003-10-06
NO20034471L NO20034471L (no) 2003-12-03

Family

ID=8497368

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034471A NO20034471L (no) 2001-04-06 2003-10-06 Aryl (eller heteroaryl)-azolylkarbinolderivater for behandling av respiratoriske sykdommer

Country Status (22)

Country Link
US (1) US20040142994A1 (no)
EP (1) EP1384476B1 (no)
JP (1) JP2004531511A (no)
KR (1) KR20040025913A (no)
CN (1) CN1230165C (no)
AT (1) ATE289812T1 (no)
AU (1) AU2002246151B2 (no)
BR (1) BR0208807A (no)
CA (1) CA2443015A1 (no)
DE (1) DE60203106T2 (no)
DK (1) DK1384476T3 (no)
ES (2) ES2174756B2 (no)
HU (1) HUP0400925A3 (no)
IL (1) IL158268A0 (no)
MX (1) MXPA03009125A (no)
NO (1) NO20034471L (no)
NZ (1) NZ529303A (no)
PL (1) PL365251A1 (no)
PT (1) PT1384476E (no)
RU (1) RU2294198C2 (no)
WO (1) WO2002080908A1 (no)
ZA (1) ZA200308630B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1820502A1 (en) * 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.

Also Published As

Publication number Publication date
CN1230165C (zh) 2005-12-07
MXPA03009125A (es) 2005-04-11
HUP0400925A2 (hu) 2004-07-28
RU2003132456A (ru) 2005-04-10
JP2004531511A (ja) 2004-10-14
AU2002246151C1 (en) 2002-10-21
EP1384476B1 (en) 2005-03-02
PL365251A1 (en) 2004-12-27
US20040142994A1 (en) 2004-07-22
HUP0400925A3 (en) 2004-10-28
PT1384476E (pt) 2005-05-31
ES2174756B2 (es) 2003-11-16
RU2294198C2 (ru) 2007-02-27
ES2236497T3 (es) 2005-07-16
ZA200308630B (en) 2004-11-05
NO20034471L (no) 2003-12-03
KR20040025913A (ko) 2004-03-26
DE60203106D1 (de) 2005-04-07
CN1535147A (zh) 2004-10-06
IL158268A0 (en) 2004-05-12
AU2002246151B2 (en) 2007-05-31
DK1384476T3 (da) 2005-05-30
WO2002080908A1 (es) 2002-10-17
NZ529303A (en) 2005-06-24
EP1384476A1 (en) 2004-01-28
ATE289812T1 (de) 2005-03-15
DE60203106T2 (de) 2006-04-13
ES2174756A1 (es) 2002-11-01
CA2443015A1 (en) 2002-10-17
BR0208807A (pt) 2004-07-13

Similar Documents

Publication Publication Date Title
GEP20104973B (en) Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
NO20064577L (no) Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
NO20090216L (no) Forbindelser med CRTH2 antagonistaktivitet
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
CY1115533T1 (el) Παραγωγα χολικου οξεος ως προσδετες fxr για την προληψη ή τη θεραπευτικη αγωγη νοσηματων ή καταστασεων οι οποιες προκαλουνται με τη μεσολαβηση fxr
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
CY1105113T1 (el) Παραγωγα της αρυλικης (ή ετepοαρυλικης) αζολυλκαρβυνολης για την αντιμετωπιση της ακρατειας ουρων
AR054127A1 (es) Imidazoquinolinas como inhibidores de quinasa de lipido
LTC1755590I2 (lt) Glikopirolato ir beta2 adrenoceptoriaus agonisto derinys
SE0200411D0 (sv) Novel use
NO20054852L (no) GFAT inhibitorer
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20074441L (no) 1-benzylindol-2-karboksamidderivater
NO20054848L (no) Substituerte p-diaminobenzenderivater
NO20045002L (no) (1-4-piperidinyl) benzimidazolderivater som kan anvendes som histamin H3-antagonister
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
WO2009095792A3 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
MX2010008360A (es) Derivados de oxazepinopirimidona heteroarilamida sustituidos.
NO20092058L (no) Heteroaryl pyrrolidinyl ketonderivater
NO20054721L (no) Substituerte anilinderivater
NO20034471D0 (no) Aryl (eller heteroaryl)-azolylkarbinolderivater for behandling av respiratoriske sykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application